Valuation Daebongls.Co.,Ltd.

Equities

End-of-day quote Korea S.E. Other stock markets 22/01/2026			5-day change	1st Jan Change
11,770.00 ^KRW	-1.09%		+6.32%	+1.03%

14/11	Daebongls.Co.,Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
06/11	Daebongls.Co.,Ltd. announces Annual dividend, payable on April 24, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2019	2020	2021	2022	2023	2024
Capitalization ¹	76,165	1,23,061	93,238	88,582	1,01,553	1,49,004
Change	-	61.57%	-24.23%	-4.99%	14.64%	46.72%
Enterprise Value (EV) ¹	52,328	58,516	40,899	24,595	59,819	1,26,969
Change	-	11.83%	-30.11%	-39.86%	143.21%	112.26%
P/E ratio	13.3x	21.1x	13.6x	10.1x	24x	20.1x
PBR	0.94x	1.18x	0.84x	0.75x	0.83x	1.12x
PEG	-	11.52x	0.8x	0.4x	-0.5x	0.3x
Capitalization / Revenue	1.1x	1.61x	1.12x	0.95x	1.16x	1.59x
EV / Revenue	0.75x	0.77x	0.49x	0.26x	0.68x	1.35x
EV / EBITDA	5.4x	5.46x	3.24x	2.18x	8.31x	10.3x
EV / EBIT	7.12x	7.2x	4.22x	3.01x	15.7x	14.2x
EV / FCF	-13.3x	7.76x	-122x	-13.8x	-12.9x	-17.6x
FCF Yield	-7.53%	12.9%	-0.82%	-7.25%	-7.77%	-5.67%
Dividend per Share ²	50	50	50	50	50	50
Rate of return	0.73%	0.45%	0.59%	0.63%	0.55%	0.37%
EPS ²	516.5	526	619	788	382	670
Distribution rate	9.68%	9.51%	8.08%	6.35%	13.1%	7.46%
Net sales ¹	69,537	76,255	82,957	93,504	87,622	93,954
EBITDA ¹	9,689	10,717	12,623	11,289	7,199	12,361
EBIT ¹	7,352	8,122	9,685	8,174	3,801	8,966
Net income ¹	5,727	5,821	6,789	8,628	4,182	7,339
Net Debt ¹	-23,837	-64,545	-52,339	-63,987	-41,734	-22,034
Reference price ²	6,870.00	11,100.00	8,410.00	7,990.00	9,160.00	13,440.00
Nbr of stocks (in thousands)	11,087	11,087	11,087	11,087	11,087	11,087
Announcement Date	18/03/20	22/03/21	21/03/22	21/03/23	20/03/24	21/03/25

¹KRW in Million²KRW

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
DAEBONGLS.CO.,LTD.	-	-	-	-	8.91Cr
ELI LILLY AND COMPANY	47.41x	15.69x	34.96x	0.54%	97TCr
JOHNSON & JOHNSON	21.13x	5.88x	16.33x	2.36%	53TCr
ABBVIE INC.	63.2x	7.25x	17.38x	3%	39TCr
ROCHE HOLDING AG	20.86x	5.07x	12.57x	2.85%	38TCr
ASTRAZENECA PLC	28.05x	5.22x	15.48x	1.77%	28TCr
NOVARTIS AG	20.34x	5.38x	12.66x	2.82%	28TCr
NOVO NORDISK A/S	17.17x	6.07x	12.54x	2.93%	28TCr
MERCK & CO., INC.	13.98x	4.56x	9.84x	2.96%	27TCr
AMGEN INC.	27.12x	6.37x	10.91x	2.76%	19TCr
Average	28.81x	6.83x	15.85x	2.44%	35.6TCr
Weighted average by Cap.	32.80x	8.47x	19.71x	2.08%